Clinical Trials Directory

Trials / Unknown

UnknownNCT02388893

Endocarditis Registry of the University Hospital of Cologne (ER-UHC)

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University of Cologne · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

As recommended in the Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (IE) patients with IE should be evaluated and managed by a multispecialty team including an cardiologist, infectious disease specialist, and cardiac surgeon. Our registry is a prospective, national registry of patients with IE. From January 2013 data from endocarditis board were prospectively recorded using standard definitions during the hospitalization. Patient demographics, clinical, laboratory, and imaging data at the time of IE diagnosis, as well as treatment outcomes were entered into the ER-UHC database.

Detailed description

The primary endpoint will be the 1 year all-cause mortality after treatment begins of IE. We will use 1 year all-cause mortality as the primary endpoint because it has been demonstrated that a period of at least 6 months is necessary to offset the early postoperative mortality related to valve surgery. We also looked at all-cause in-hospital mortality as a secondary endpoint.

Conditions

Timeline

Start date
2013-01-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2015-03-17
Last updated
2018-10-17

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02388893. Inclusion in this directory is not an endorsement.